ReWalk Robotics Ltd. (RWLK) Income Statement Analysis

See more : More Provident Funds Ltd (MPP.TA) Income Statement Analysis – Financial Results

Complete financial analysis of ReWalk Robotics Ltd. (RWLK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of ReWalk Robotics Ltd., a leading company in the Medical – Devices industry within the Healthcare sector.

You may be interested

ReWalk Robotics Ltd. (RWLK)

Industry: Medical - Devices

Sector: Healthcare

Website: https://www.rewalk.com

About ReWalk Robotics Ltd.

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.

Metric	2023	2022	2021	2020	2019	2018	2017	2016
Revenue	13.85M	5.51M	5.97M	4.39M	4.87M	6.55M	7.75M	5.87M
Cost of Revenue	9.40M	3.61M	3.06M	2.20M	2.15M	3.72M	4.65M	5.13M
Gross Profit	4.45M	1.91M	2.90M	2.19M	2.73M	2.83M	3.10M	736.00K
Gross Profit Ratio	32.14%	34.57%	48.66%	49.83%	55.94%	43.16%	40.00%	12.54%
Research & Development	4.15M	4.03M	2.94M	3.46M	5.35M	7.35M	6.04M	9.03M
General & Administrative	10.00M	7.13M	5.63M	4.98M	0.00	0.00	0.00	0.00
Selling & Marketing	13.92M	9.84M	6.99M	5.75M	0.00	0.00	0.00	0.00
SG&A	23.92M	16.98M	12.62M	10.73M	11.43M	14.69M	19.05M	22.15M
Other Expenses	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Expenses	28.07M	21.01M	15.56M	14.19M	16.77M	22.04M	25.09M	31.18M
Cost & Expenses	37.47M	24.61M	18.62M	16.40M	18.92M	25.76M	29.75M	36.31M
Interest Income	1.35M	0.00	0.00	0.00	0.00	0.00	0.00	-1.00
Interest Expense	20.00K	22.00K	25.00K	907.00K	1.53M	2.42M	2.48M	2.01M
Depreciation & Amortization	1.85M	202.00K	266.00K	285.00K	321.00K	463.00K	642.00K	696.00K
EBITDA	-21.77M	-18.90M	-12.39M	-11.73M	-13.72M	-18.79M	-21.48M	-29.79M
EBITDA Ratio	-157.10%	-343.35%	-208.30%	-267.29%	-281.70%	-286.49%	-275.38%	-506.82%
Operating Income	-23.61M	-19.10M	-12.66M	-12.00M	-14.05M	-19.21M	-21.99M	-30.44M
Operating Income Ratio	-170.43%	-346.62%	-212.12%	-273.25%	-288.28%	-293.57%	-283.66%	-518.67%
Total Other Income/Expenses	1.47M	0.00	13.00K	-921.00K	-1.50M	-2.47M	-2.61M	-2.06M
Income Before Tax	-22.15M	-19.10M	-12.64M	-12.93M	-15.54M	-21.68M	-24.60M	-32.50M
Income Before Tax Ratio	-159.85%	-346.62%	-211.90%	-294.22%	-318.98%	-331.25%	-317.27%	-553.76%
Income Tax Expense	-12.00K	467.00K	94.00K	51.00K	7.00K	-5.00K	119.00K	3.00K
Net Income	-22.13M	-19.57M	-12.74M	-12.98M	-15.55M	-21.68M	-24.72M	-32.50M
Net Income Ratio	-159.76%	-355.09%	-213.48%	-295.38%	-319.13%	-331.17%	-318.81%	-553.81%
EPS	-2.59	-2.20	-1.86	-5.74	-18.90	-103.04	-213.98	-431.63
EPS Diluted	-2.59	-2.20	-1.86	-5.74	-18.90	-103.04	-213.98	-431.63
Weighted Avg Shares Out	8.53M	8.91M	6.85M	2.25M	823.33K	210.36K	115.51K	75.30K
Weighted Avg Shares Out (Dil)	8.53M	8.91M	6.85M	2.25M	823.33K	210.36K	115.51K	75.30K

ReWalk Robotics to Report Third Quarter 2023 Financial Results on November 14, 2023

November 7, 2023globenewswire.com

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Nov. 07, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its third quarter 2023 financial results on Tuesday, November 14,...

Medicare Coverage Solidified for ReWalk Personal Exoskeleton

November 2, 2023globenewswire.com

2024 Medicare Home Health Rule finalizes Medicare benefit category for personal exoskeletons. Final rule expedites access for Medicare beneficiaries to exoskeleton technology that enables individuals with spinal cord injury to stand, walk, and navigate stairs and curbs in everyday life.

The 3 Best Penny Stocks to Buy in November

October 31, 2023investorplace.com

When it comes to extremely speculative, low-priced securities, you need to exercise extreme caution, even if they're labeled as the best penny stocks to buy. Consider this term as euphemism for don't buy these incredibly risky ideas unless you perform...

ReWalk Robotics Exhibits at the GITEX GLOBAL Intelligent Connectivity / AI Pavilion

October 18, 2023globenewswire.com

A key theme for the event is that 2023 marks “The Year to imagine AI in Everything”. A key theme for the event is that 2023 marks “The Year to imagine AI in Everything”.

ReWalk Robotics Offers Thanks to Former Director for His Loyal Service and Valuable Contributions

September 20, 2023globenewswire.com

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Sept. 20, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “the Company”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for...

ReWalk Robotics Ltd. to Present Virtually at H.C.

September 6, 2023globenewswire.com

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Sept. 06, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) announced that Larry Jasinski, Chief Executive Officer, will present and host one-on-one meetings with investors virtually at the H.C. Wainwright...